Kerry Wentworth, VP, Clin, Reg & Quality at ANTIGENICS INC /DE/ (AGEN), sold 102,316 shares at $0.85 ($87K) on 2010-01-20, disclosed to the SEC on 2010-01-22.
Scheduled sale ($87k) by VP, Clin, Reg & Quality under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NUVB | SELL | 2026-04-08 | $904K | — | Filing → |
| NUVB | BUY | 2025-06-18 | $90K | — | Filing → |
| FLXN | SELL | 2021-07-20 | $25K | — | Filing → |